Blindness is the most feared medical condition in the nation.1 Second only to the fear of death is the fear of living a life without the benefit of the sense of sight.2
I enjoy good continuing education. Compelling lectures with high-resolution images keep me engaged, and I enjoy the act of silently quizzing myself to see if I can predict the correct diagnosis of an interesting case presentation.
Given that allergies are the sixth leading cause of chronic illness in the United States with an estimated annual cost of greater than $18 billion1 and that 40 to 60 percent of those affected experience ocular involvement,
More efficient and comprehensive telemedicine instrumentation is increasingly combined with even more accurate artificial intelligence (AI).
Recent mergers, acquisitions, and drug patent battles in the pharmaceutical space have led to changes in the ocular pharmaceutical pipeline.
A fungal infection in my left ear last spring left me pondering topics relevant to all would-be healers, such as:
• Dangers of self-treatment by healthcare professionals
• Appropriate use of opioids
I have heard doctors of various specialties refer to their Drug Enforcement Agency (DEA) license fees as no more than taxes and prescription drug monitoring programs as government overreach.
“Oops”—it is a short, one-syllable word that most of us use on occasion—but never by surgeons.
As happens every Jan. 1, new laws go into effect. One that will impact every contracted Vision Service Plan (VSP) provider—that most don’t even realize affects them—is a change in the California Health and Safety Code.1